北京万东医疗科技股份有限公司 关于以集中竞价交易方式回购股份的进展公告

Group 1 - The company approved a share repurchase plan using its own funds, with a total amount ranging from RMB 30 million to 60 million, and a maximum repurchase price of RMB 25 per share [2] - The implementation period for the share repurchase is set for 12 months from the date of the board meeting approval [2] - As of August 29, 2025, the company has not yet conducted any share repurchases [2][3] Group 2 - The company has opened a dedicated account for the share repurchase and is in the process of setting up the corresponding funding accounts [2] - The company will make repurchase decisions based on market conditions and will fulfill its information disclosure obligations in a timely manner [3]